Public research preview

Undisclosed SIX management transaction party T1Q5Q00051, A non-executive member of the board of directors of Kuros Biosciences Ltd.

Disclosed a sell transaction in Kuros Biosciences Ltd.. Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Noch frisch
99/100
Signalqualität
57/100
Datenvertrauen
91%
high

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
SIX management transactions
Published
26 May 2026, 00.00
Parser confidence
96%
Instrument mapping
85%
Filing delay
0 days

Timeline

Transaction date

26 May 2026

Public disclosure

26 May 2026

Now

Tracked today

Filing delay: 0 days

Price movement

Complete coverage

Provider
EODHD global daily close
Fetched
5 Jun 2026

Stock path

KURN from pre-transaction context through latest close.

Transaction

26 May 2026 · 21,94 CHF

18,822,325,8CHFDate17 Mar26 May5 JunTransactionLatest
Observed transaction close
21,94
Observed disclosure close
21,94
Observed latest close
20,62
Pre-disclosure move
0.0%
Post-disclosure move
-6.0%
Market-adjusted move
-6.0%

Why Copy Window is Still fresh

Supporting factors

  • Parsed sell disclosure for ordinary shares from SIX management transactions.
  • Transaction value is CHF 139,385.
  • Post-disclosure move is calculated from EODHD global daily close daily closes.

Cautions

  • EODHD global daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

SIX management transactions, published 26 May 2026, 00.00

View source
Parser confidence
96%
Instrument mapping
85%
FieldExtracted value
isinCH0325814116
roleA non-executive member of the board of directors
sidesell
value139385.36
sourcesix_management_transactions
volume7225
currencyCHF
assetTypestock
sourceUrlhttps://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5Q00051
personNameUndisclosed SIX management transaction party T1Q5Q00051
companyNameKuros Biosciences Ltd.
publishedAt2026-05-26T00:00:00.000Z
rawDocumentIdraw-ch-six-4bfc54cd9456
disclosureDate2026-05-26
transactionDate2026-05-26